Team |
Tyler McCullough, PhD
Tyler McCullough, PhD

Tyler McCullough, PhD

Senior Scientist

Preclinical Development

Tyler is responsible for advancing translatable indications as a part of the Preclinical Development team at Life Edit, leveraging over eight years of experience in the gene therapy and gene editing fields using a variety of preclinical models.

Before joining Life Edit, Tyler worked as a post-doctoral fellow at Duke University investigating the consequences of immunological responses against in vivo gene editing in order to advance therapeutic strategies for Duchenne’s Muscular Dystrophy.

Previously, Tyler received his Master of Health Science at Johns Hopkins School of Public Health and went on to work with the FDA for a short time before completing his PhD in Genetics from his undergraduate alma mater, the University of Florida (Go Gators!). During his graduate studies there, he helped develop a CRISPR-based strategy to treat congenital blindness.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.